Personal profile
Personal profile
Dr. Solomon began his clinical cardiology career at the Diagnostic Clinic of Houston in 1983. He is Board Certified in internal medicine with a subspecialty board in cardiovascular disease and a special added qualification in interventional cardiology. Dr. Solomon received his first academic appointment in 1984 as an Instructor of Internal Medicine at The University of Texas Medical School in Houston, Texas. He later joined the faculty at the Baylor College of Medicine in 1999 as a Clinical Associate Professor in the Department of Internal Medicine.
Research interests
Dr. Solomon has substantial experience in clinical research having served as an investigator or co-investigator on numerous clinical trials.
Free-text keywords
- Cardiology
- Investigational new drugs
- Clinical trails
Fingerprint
- 1 Similar Profiles
Research output
- 9 Article
-
A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions. 12-Month Outcomes From the ENDEAVOR IV Trial
Leon, M. B., Mauri, L., Popma, J. J., Cutlip, D. E., Nikolsky, E., O'Shaughnessy, C., Overlie, P. A., McLaurin, B. T., Solomon, S. L., Douglas, J. S., Ball, M. W., Caputo, R. P., Jain, A., Tolleson, T. R., Reen, B. M., Kirtane, A. J., Fitzgerald, P. J., Thompson, K. & Kandzari, D. E., Feb 9 2010, In: Journal of the American College of Cardiology. 55, 6, p. 543-554 12 p.Research output: Contribution to journal › Article › peer-review
227 Link opens in a new tab Scopus citations -
Clinical and Angiographic Outcomes in Diabetics From the ENDEAVOR IV Trial. Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
Kirtane, A. J., Patel, R., O'Shaughnessy, C., Overlie, P., McLaurin, B., Solomon, S., Mauri, L., Fitzgerald, P., Popma, J. J., Kandzari, D. E. & Leon, M. B., Oct 2009, In: JACC: Cardiovascular Interventions. 2, 10, p. 967-976 10 p.Research output: Contribution to journal › Article › peer-review
48 Link opens in a new tab Scopus citations -
Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions. 2-Year Follow-Up From the ENDEAVOR IV Trial
Leon, M. B., Kandzari, D. E., Eisenstein, E. L., Anstrom, K. J., Mauri, L., Cutlip, D. E., Nikolsky, E., O'Shaughnessy, C., Overlie, P. A., Kirtane, A. J., McLaurin, B. T., Solomon, S. L., Douglas, J. S. & Popma, J. J., Dec 2009, In: JACC: Cardiovascular Interventions. 2, 12, p. 1208-1218 11 p.Research output: Contribution to journal › Article › peer-review
58 Link opens in a new tab Scopus citations -
Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions
Atmakuri, S. R., Lev, E. I., Alviar, C., Ibarra, E., Raizner, A. E., Solomon, S. L. & Kleiman, N. S., Feb 7 2006, In: Journal of the American College of Cardiology. 47, 3, p. 515-521 7 p.Research output: Contribution to journal › Article › peer-review
66 Link opens in a new tab Scopus citations -
Initial impact of drug-eluting stent use on the spectrum of patients undergoing percutaneous coronary intervention
Lev, E. I., Tayyan, N., Raizner, A. E., Solomon, S. L., Simmons, D. & Kleiman, N. S., Jun 1 2006, In: Coronary Artery Disease. 17, 4, p. 379-384 6 p.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Scopus citations